174 related articles for article (PubMed ID: 12659687)
1. In vitro and in vivo pharmacology and pharmacokinetics of a human engineered monoclonal antibody to epithelial cell adhesion molecule.
Ammons WS; Bauer RJ; Horwitz AH; Chen ZJ; Bautista E; Ruan HH; Abramova M; Scott KR; Dedrick RL
Neoplasia; 2003; 5(2):146-54. PubMed ID: 12659687
[TBL] [Abstract][Full Text] [Related]
2. ING-1(heMAb), a monoclonal antibody to epithelial cell adhesion molecule, inhibits tumor metastases in a murine cancer model.
Ruan HH; Scott KR; Bautista E; Ammons WS
Neoplasia; 2003; 5(6):489-94. PubMed ID: 14965442
[TBL] [Abstract][Full Text] [Related]
3. ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas.
de Bono JS; Tolcher AW; Forero A; Vanhove GF; Takimoto C; Bauer RJ; Hammond LA; Patnaik A; White ML; Shen S; Khazaeli MB; Rowinsky EK; LoBuglio AF
Clin Cancer Res; 2004 Nov; 10(22):7555-65. PubMed ID: 15569986
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment.
Naundorf S; Preithner S; Mayer P; Lippold S; Wolf A; Hanakam F; Fichtner I; Kufer P; Raum T; Riethmüller G; Baeuerle PA; Dreier T
Int J Cancer; 2002 Jul; 100(1):101-10. PubMed ID: 12115595
[TBL] [Abstract][Full Text] [Related]
5. Preparation of human IgG and IgM monoclonal antibodies for MK-1/Ep-CAM by using human immunoglobulin gene-transferred mouse and gene cloning of their variable regions.
Kuroki M; Yamada H; Shibaguchi H; Hachimine K; Hirose Y; Kinugasa T; Ishida I; Kuroki M
Anticancer Res; 2005; 25(6A):3733-9. PubMed ID: 16302733
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineere monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors.
Goel S; Bauer RJ; Desai K; Bulgaru A; Iqbal T; Strachan BK; Kim G; Kaubisch A; Vanhove GF; Goldberg G; Mani S
Ann Oncol; 2007 Oct; 18(10):1704-7. PubMed ID: 17693421
[TBL] [Abstract][Full Text] [Related]
7. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.
Wolff EA; Schreiber GJ; Cosand WL; Raff HV
Cancer Res; 1993 Jun; 53(11):2560-5. PubMed ID: 8495420
[TBL] [Abstract][Full Text] [Related]
9. Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines.
Prang N; Preithner S; Brischwein K; Göster P; Wöppel A; Müller J; Steiger C; Peters M; Baeuerle PA; da Silva AJ
Br J Cancer; 2005 Jan; 92(2):342-9. PubMed ID: 15655555
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibody.
Graves SS; Goshorn SC; Stone DM; Axworthy DB; Reno JM; Bottino B; Searle S; Henry A; Pedersen J; Rees AR; Libby RT
Clin Cancer Res; 1999 Apr; 5(4):899-908. PubMed ID: 10213227
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody.
Roovers RC; van der Linden E; de Bruïne AP; Arends JW; Hoogenboom HR
Cancer Immunol Immunother; 2001 Mar; 50(1):51-9. PubMed ID: 11315510
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
13. The murine homolog of human Ep-CAM, a homotypic adhesion molecule, is expressed by thymocytes and thymic epithelial cells.
Nelson AJ; Dunn RJ; Peach R; Aruffo A; Farr AG
Eur J Immunol; 1996 Feb; 26(2):401-8. PubMed ID: 8617310
[TBL] [Abstract][Full Text] [Related]
14. A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments.
Huls GA; Heijnen IA; Cuomo ME; Koningsberger JC; Wiegman L; Boel E; van der Vuurst de Vries AR; Loyson SA; Helfrich W; van Berge Henegouwen GP; van Meijer M; de Kruif J; Logtenberg T
Nat Biotechnol; 1999 Mar; 17(3):276-81. PubMed ID: 10096296
[TBL] [Abstract][Full Text] [Related]
15. Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody.
Wimberger P; Xiang W; Mayr D; Diebold J; Dreier T; Baeuerle PA; Kimmig R
Int J Cancer; 2003 Jun; 105(2):241-8. PubMed ID: 12673686
[TBL] [Abstract][Full Text] [Related]
16. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.
Huls G; Heijnen IA; Cuomo E; van der Linden J; Boel E; van de Winkel JG; Logtenberg T
Cancer Res; 1999 Nov; 59(22):5778-84. PubMed ID: 10582699
[TBL] [Abstract][Full Text] [Related]
17. Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct.
Schlereth B; Fichtner I; Lorenczewski G; Kleindienst P; Brischwein K; da Silva A; Kufer P; Lutterbuese R; Junghahn I; Kasimir-Bauer S; Wimberger P; Kimmig R; Baeuerle PA
Cancer Res; 2005 Apr; 65(7):2882-9. PubMed ID: 15805290
[TBL] [Abstract][Full Text] [Related]
18. Specific targeting of Ep-CAM in various carcinomas by novel monoclonal antibodies.
Sithambaram D; Palanivelu S; Subramanian K; Sahoo S; Verma RS
Hybridoma (Larchmt); 2011 Dec; 30(6):511-8. PubMed ID: 22149275
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3.
Schlereth B; Kleindienst P; Fichtner I; Lorenczewski G; Brischwein K; Lippold S; da Silva A; Locher M; Kischel R; Lutterbüse R; Kufer P; Baeuerle PA
Cancer Immunol Immunother; 2006 Jul; 55(7):785-96. PubMed ID: 16187083
[TBL] [Abstract][Full Text] [Related]
20. CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo.
Trikha M; Zhou Z; Nemeth JA; Chen Q; Sharp C; Emmell E; Giles-Komar J; Nakada MT
Int J Cancer; 2004 Jun; 110(3):326-35. PubMed ID: 15095296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]